No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
VKTX241227C41000
- 2.55
- +0.25+10.87%
15min DelayClose Dec 20 16:00 ET
4.60High2.55Low
3.00Open2.30Pre Close217 Volume239 Open Interest41.00Strike Price82.94KTurnover71.73%IV3.08%PremiumDec 27, 2024Expiry Date1.25Intrinsic Value100Multiplier4DDays to Expiry1.30Extrinsic Value100Contract SizeAmericanOptions Type0.6645Delta0.1087Gamma20.61Leverage Ratio-0.1472Theta0.0032Rho13.69Eff Leverage0.0170Vega
Intraday
- 5D
- Daily
News
Why Viking Therapeutics Tumbled by More Than 10% This Week
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla -- WSJ
B.Riley Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $109
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)